- Home
- TMUS vs NVS Comparison
TMUS vs NVS Comparison
Compare TMUS & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMUS
- NVS
- Stock Information
- Founded
- TMUS 1994
- NVS 1895
- Country
- TMUS United States
- NVS Switzerland
- Employees
- TMUS N/A
- NVS N/A
- Industry
- TMUS Telecommunications Equipment
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- TMUS Telecommunications
- NVS Health Care
- Exchange
- TMUS Nasdaq
- NVS Nasdaq
- Market Cap
- TMUS 268.3B
- NVS 248.3B
- IPO Year
- TMUS N/A
- NVS 1991
- Fundamental
- Price
- TMUS $226.85
- NVS $131.66
- Analyst Decision
- TMUS Buy
- NVS Sell
- Analyst Count
- TMUS 22
- NVS 4
- Target Price
- TMUS $260.19
- NVS $119.00
- AVG Volume (30 Days)
- TMUS 4.2M
- NVS 1.3M
- Earning Date
- TMUS 10-23-2025
- NVS 10-28-2025
- Dividend Yield
- TMUS 1.55%
- NVS 1.97%
- EPS Growth
- TMUS 32.79
- NVS N/A
- EPS
- TMUS 10.59
- NVS 6.85
- Revenue
- TMUS $84,052,000,000.00
- NVS $55,186,000,000.00
- Revenue This Year
- TMUS $9.50
- NVS $9.06
- Revenue Next Year
- TMUS $6.01
- NVS $2.54
- P/E Ratio
- TMUS $21.50
- NVS $19.20
- Revenue Growth
- TMUS 6.27
- NVS 12.95
- 52 Week Low
- TMUS $207.41
- NVS $96.06
- 52 Week High
- TMUS $276.49
- NVS $133.55
- Technical
- Relative Strength Index (RSI)
- TMUS 31.56
- NVS 67.10
- Support Level
- TMUS $222.26
- NVS $122.21
- Resistance Level
- TMUS $240.86
- NVS $133.55
- Average True Range (ATR)
- TMUS 4.72
- NVS 1.61
- MACD
- TMUS -1.10
- NVS 0.77
- Stochastic Oscillator
- TMUS 27.57
- NVS 83.33
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 80 million postpaid and 25 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.